Table 3.

Effects of tualang honey, glibenclamide, metformin or their combinations on triglycerides (TG), total cholesterol (TC), high density lipoprotein (HDL) cholesterol, low density lipoprotein (LDL) cholesterol and very low density lipoprotein (VLDL) cholesterol in the serum of streptozotocin-induced diabetic rats.

Group	TG (mg/dL)	TC (mg/dL)	HDL-C (mg/dL)	LDL-C (mg/dL)	VLDL-C (mg/dL)
Non-diabetic control	0.44 ± 0.04	1.50 ± 0.15	0.81 ± 0.08	0.42 ± 0.07	0.20 ± 0.02
Non-diabetic + Honey	0.51 ± 0.02	1.60 ± 0.11	0.88 ± 0.03	0.49 ± 0.08	0.23 ± 0.01
Diabetic control	0.71 ± 0.21	1.52 ± 0.09	0.75 ± 0.09	0.39 ± 0.04	0.32 ± 0.10
Diabetic + Honey	0.25 ± 0.04*,†	1.42 ± 0.12	0.89 ± 0.09†	0.38 ± 0.05	0.14 ± 0.03†
Diabetic + Glibenclamide	0.30 ± 0.08†	1.07 ± 0.07*,††	0.64 ± 0.09	0.29 ± 0.03	0.14 ± 0.04†
Diabetic + Glibenclamide + Honey	0.21 ± 0.04**,†	1.14 ± 0.08†	0.82 ± 0.12	0.41 ± 0.03	0.10 ± 0.02**,†
Diabetic + Metformin	0.38 ± 0.19*,†	1.38 ± 0.16	0.87 ± 0.09	0.34 ± 0.03	0.17 ± 0.08*,†
Diabetic + Metformin + Honey	0.17 ± 0.02**,††	0.89 ± 0.15*,†	0.67 ± 0.11	0.24 ± 0.04†	0.07 ± 0.01**,†

Data are expressed as mean ± SEM. Each group consisted of five to seven animals. Values are statistically significant at * p < 0.05, ** p < 0.01 compared to non-diabetic control; † p < 0.05, †† p < 0.01 compared to diabetic control.